Literature DB >> 32472768

Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.

Jane Kabami1,2, Laura B Balzer3, Hachem Saddiki3, James Ayieko4, Dalsone Kwarisiima2, Mucunguzi Atukunda2, Edwin D Charlebois5, Tamara D Clark5, Catherine A Koss5, Theodore Ruel5, Elizabeth A Bukusi4, Craig R Cohen5, Phillipa Musoke1, Maya L Petersen6, Diane V Havlir5, Moses R Kamya1,2, Gabriel Chamie5.   

Abstract

OBJECTIVE(S): We sought to determine whether universal 'test and treat' (UTT) can achieve gains in viral suppression beyond universal antiretroviral treatment (ART) eligibility during pregnancy and postpartum, among women living with HIV.
DESIGN: A community cluster randomized trial.
METHODS: The SEARCH UTT trial compared an intervention of annual population testing and universal ART with a control of baseline population testing with ART by country standard, including ART eligibility for all pregnant/postpartum women, in 32 communities in Kenya and Uganda. When testing, women were asked about current pregnancy and live births over the prior year and, if HIV-infected, had their viral load measured. Between arms, we compared population-level viral suppression (HIV RNA <500 copies/ml) among all pregnant/postpartum HIV-infected women at study close (year 3). We also compared year-3 population-level viral suppression and predictors of viral suppression among all 15 to 45-year-old women by arm.
RESULTS: At baseline, 92 and 93% of 15 to 45-year-old women tested for HIV: HIV prevalence was 12.6 and 12.3%, in intervention and control communities, respectively. Among HIV-infected women self-reporting pregnancy/live birth, prevalence of viral suppression was 42 and 44% at baseline, and 81 and 76% (P = 0.02) at year 3, respectively. Among all 15 to 45-year-old HIV-infected women, year-3 population-level viral suppression was higher in intervention (77%) versus control (68%; P < 0.001). Pregnancy/live birth was a predictor of year-3 viral suppression in control (P = 0.016) but not intervention (P = 0.43). Younger age was a risk factor for nonsuppression in both arms.
CONCLUSION: The SEARCH intervention resulted in higher population viral suppression among pregnant/postpartum women than a control of baseline universal testing with ART eligibility for pregnant/postpartum women.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32472768      PMCID: PMC7360881          DOI: 10.1097/QAD.0000000000002564

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  22 in total

1.  Adaptive pre-specification in randomized trials with and without pair-matching.

Authors:  Laura B Balzer; Mark J van der Laan; Maya L Petersen
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

2.  Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Authors:  Isabelle de Vincenzi
Journal:  Lancet Infect Dis       Date:  2011-01-13       Impact factor: 25.071

3.  Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus-infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study.

Authors:  Landon Myer; Andrew D Redd; Elton Mukonda; Briana A Lynch; Tamsin K Phillips; Anna Eisenberg; Nei-Yuan Hsiao; Adam Capoferri; Alison Zerbe; William Clarke; Maia Lesosky; Autumn Breaud; James McIntyre; Daniel Bruno; Craig Martens; Elaine J Abrams; Steven J Reynolds
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

4.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

5.  Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

Authors:  Joseph Makhema; Kathleen E Wirth; Molly Pretorius Holme; Tendani Gaolathe; Mompati Mmalane; Etienne Kadima; Unoda Chakalisa; Kara Bennett; Jean Leidner; Kutlo Manyake; Atang M Mbikiwa; Selebaleng V Simon; Rona Letlhogile; Kutlwano Mukokomani; Erik van Widenfelt; Sikhulile Moyo; Refeletswe Lebelonyane; Mary G Alwano; Kathleen M Powis; Scott L Dryden-Peterson; Coulson Kgathi; Vlad Novitsky; Janet Moore; Pamela Bachanas; William Abrams; Lisa Block; Shenaaz El-Halabi; Tafireyi Marukutira; Lisa A Mills; Connie Sexton; Elliot Raizes; Simani Gaseitsiwe; Hermann Bussmann; Lillian Okui; Oaitse John; Roger L Shapiro; Sherri Pals; Haben Michael; Michelle Roland; Victor DeGruttola; Quanhong Lei; Rui Wang; Eric Tchetgen Tchetgen; M Essex; Shahin Lockman
Journal:  N Engl J Med       Date:  2019-07-18       Impact factor: 176.079

Review 6.  A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women.

Authors:  Ian Hodgson; Mary L Plummer; Sarah N Konopka; Christopher J Colvin; Edna Jonas; Jennifer Albertini; Anouk Amzel; Karen P Fogg
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.

Authors:  Dalsone Kwarisiima; Moses R Kamya; Asiphas Owaraganise; Florence Mwangwa; Dathan M Byonanebye; James Ayieko; Albert Plenty; Doug Black; Tamara D Clark; Bridget Nzarubara; Katherine Snyman; Lillian Brown; Elizabeth Bukusi; Craig R Cohen; Elvin H Geng; Edwin D Charlebois; Theodore D Ruel; Maya L Petersen; Diane Havlir; Vivek Jain
Journal:  J Int AIDS Soc       Date:  2017-07-21       Impact factor: 5.396

8.  Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.

Authors:  Olumuyiwa Omonaiye; Snezana Kusljic; Pat Nicholson; Elizabeth Manias
Journal:  BMC Public Health       Date:  2018-06-27       Impact factor: 3.295

9.  A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study.

Authors:  Gabriel Chamie; Tamara D Clark; Jane Kabami; Kevin Kadede; Emmanuel Ssemmondo; Rachel Steinfeld; Geoff Lavoy; Dalsone Kwarisiima; Norton Sang; Vivek Jain; Harsha Thirumurthy; Teri Liegler; Laura B Balzer; Maya L Petersen; Craig R Cohen; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Edwin D Charlebois
Journal:  Lancet HIV       Date:  2016-01-26       Impact factor: 12.767

10.  Two decades of antenatal and delivery care in Uganda: a cross-sectional study using Demographic and Health Surveys.

Authors:  Lenka Benova; Mardieh L Dennis; Isabelle L Lange; Oona M R Campbell; Peter Waiswa; Manon Haemmerli; Yolanda Fernandez; Kate Kerber; Joy E Lawn; Andreia Costa Santos; Fred Matovu; David Macleod; Catherine Goodman; Loveday Penn-Kekana; Freddie Ssengooba; Caroline A Lynch
Journal:  BMC Health Serv Res       Date:  2018-10-04       Impact factor: 2.655

View more
  1 in total

1.  Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission.

Authors:  Megan Landes; Monique van Lettow; Joep J van Oosterhout; Erik Schouten; Andrew Auld; Thokozani Kalua; Andreas Jahn; Beth A Tippett Barr
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.